Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 2
1968 2
1969 1
1970 1
1972 1
1973 1
1977 1
1979 1
1982 1
1983 2
1984 1
1985 1
1986 1
1987 2
1988 3
1989 8
1990 2
1991 3
1992 13
1993 3
1994 4
1995 12
1996 14
1997 12
1998 9
1999 5
2000 7
2001 9
2002 7
2003 10
2004 6
2005 5
2006 8
2007 9
2008 7
2009 13
2010 18
2011 17
2012 19
2013 15
2014 14
2015 15
2016 16
2017 6
2018 14
2019 3
2020 6
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 7579052

307 results
Results by year
Filters applied: . Clear all
Page 1
Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group.
Klahr S, Breyer JA, Beck GJ, Dennis VW, Hartman JA, Roth D, Steinman TI, Wang SR, Yamamoto ME. Klahr S, et al. J Am Soc Nephrol. 1995 Jun;5(12):2037-47. J Am Soc Nephrol. 1995. PMID: 7579052 Free article. Clinical Trial.
Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine concentration in the Modification of Diet in Renal Disease Study.
[No authors listed] [No authors listed] J Am Soc Nephrol. 1996 Apr;7(4):556-66. J Am Soc Nephrol. 1996. PMID: 8724889 Free article. Clinical Trial.
Effects of dietary protein restriction on the progression of moderate renal disease in the Modification of Diet in Renal Disease Study.
[No authors listed] [No authors listed] J Am Soc Nephrol. 1996 Dec;7(12):2616-26. J Am Soc Nephrol. 1996. PMID: 8989740 Free article. Clinical Trial.
Short-term effects of protein intake, blood pressure, and antihypertensive therapy on glomerular filtration rate in the Modification of Diet in Renal Disease Study.
[No authors listed] [No authors listed] J Am Soc Nephrol. 1996 Oct;7(10):2097-109. J Am Soc Nephrol. 1996. PMID: 8915969 Free article. Clinical Trial.
Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease.
Choukroun G, Itakura Y, Albouze G, Christophe JL, Man NK, Grünfeld JP, Jungers P. Choukroun G, et al. J Am Soc Nephrol. 1995 Dec;6(6):1634-42. J Am Soc Nephrol. 1995. PMID: 8749691 Free article.
Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
Zeltner R, Poliak R, Stiasny B, Schmieder RE, Schulze BD. Zeltner R, et al. Nephrol Dial Transplant. 2008 Feb;23(2):573-9. doi: 10.1093/ndt/gfm731. Epub 2007 Nov 4. Nephrol Dial Transplant. 2008. PMID: 17984104 Clinical Trial.
The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group.
Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G. Klahr S, et al. N Engl J Med. 1994 Mar 31;330(13):877-84. doi: 10.1056/NEJM199403313301301. N Engl J Med. 1994. PMID: 8114857 Free article. Clinical Trial.
The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension.
Lea J, Greene T, Hebert L, Lipkowitz M, Massry S, Middleton J, Rostand SG, Miller E, Smith W, Bakris GL. Lea J, et al. Arch Intern Med. 2005 Apr 25;165(8):947-53. doi: 10.1001/archinte.165.8.947. Arch Intern Med. 2005. PMID: 15851648 Clinical Trial.
Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.
Torres VE, King BF, Chapman AB, Brummer ME, Bae KT, Glockner JF, Arya K, Risk D, Felmlee JP, Grantham JJ, Guay-Woodford LM, Bennett WM, Klahr S, Meyers CM, Zhang X, Thompson PA, Miller JP; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP). Torres VE, et al. Clin J Am Soc Nephrol. 2007 Jan;2(1):112-20. doi: 10.2215/CJN.00910306. Epub 2006 Nov 2. Clin J Am Soc Nephrol. 2007. PMID: 17699395 Free article.
Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT Jr, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber M, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T. Rahman M, et al. Arch Intern Med. 2005 Apr 25;165(8):936-46. doi: 10.1001/archinte.165.8.936. Arch Intern Med. 2005. PMID: 15851647 Clinical Trial.
307 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback